GMH HP 75IU INJECTION

GMH HP 75IU Injection contains the active ingredient Menotrophin. Menotrophin is an Ovulation Stimulator, part of the class of medicines known as gonadotropins. It is a highly pure mix of follicle-stimulating hormone (FSH) and the hormone luteinizing (LH). They are both natural hormones created by males and females. They usually assist the reproductive organs in working.
GMH HP 75IU Injection is used to treat infertility for women who have not been able to ovulate or have polycystic Ovarian Disease and who haven’t been able to respond to treatment with a different medication known as clomiphene. It can also aid in the development of multiple follicles and, thus, promote fertility among women who undergo IVF (in-vitro fertilization) or other forms of assisted conception. It is also used for treating infertility in males because of a low sperm count.
Don’t consume GMH HP 75IU Injection if you are allergic to menotrophin or any other ingredient of this medication. Don’t use this medicine if you are suffering from an abnormal pituitary gland (a gland that is located at the brain’s base that makes certain hormones such as growth hormones) or in the hypothalamus (an area that is located beneath the brain’s surface known as the thalamus, which regulates the body’s conditions such as blood pressure and body temperature) including the ovaries, the uterus testicles, breasts or the prostate gland. Before you begin treatment, you’ll be evaluated for thyroid issues, hormone levels, and tumors in the hypothalamus and pituitary glands.
Do not take this medication if you suffer from cysts in your ovaries that are not caused by PCOD vaginal bleeding, menopausal symptoms, or physical issues within your reproductive organs if your womb was removed or if you are breastfeeding or pregnant. Tell your doctor immediately if you are experiencing any of these symptoms, including abdominal pain and swelling and weight growth, diarrhea, difficulty breathing, or a decrease in urine output. Inform your doctor if you’ve suffered from liver issues or a history of blood clotting disease before starting treatment.